Ilonka Zsolt (I Zsolt)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 3

Top Topics

Staphylococcus Aureus

Candida Albicans

Cystic Fibrosis

Top Venues

ClinicoEconomics and outcomes research : CEOR

International journal of molecular sciences

Ferrer Internacional S.A.

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Ferrer Internacional S.A. Jun 01 2000

Spain

Senior Corporate Medical Advisror :: Corporate Medical Department

Publications

Alberto Cordero-Fort, Regina Dalmau González-Gallarza, Lluis Masana, Valentín Fuster, Jose Mª Castellano, José Emilio Ruiz Olivar, Ilonka Zsolt, Antoni Sicras Mainar, Jose Ramón González Juanatey
Economic Burden Associated with the Treatment with a Cardiovascular Polypill in Secondary Prevention in Spain: Cost-Effectiveness Results of the NEPTUNO Study. ClinicoEconomics and outcomes research : CEOR 15 (2023)
Yuly López, Laura Muñoz, Domingo Gargallo-Viola, Rafael Cantón, Jordi Vila, Ilonka Zsolt
Uptake of Ozenoxacin and Other Quinolones in Gram-Positive Bacteria. International journal of molecular sciences 22 (24) (2021)
Y López, M Tato, D Gargallo-Viola, R Cantón, J Vila, Ilonka Zsolt
Mutant prevention concentration of ozenoxacin for quinolone-susceptible or -resistant Staphylococcus aureus and Staphylococcus epidermidis. PloS one 14 (10) (2019)